Solubility of triamcinolone acetonide and other anti-inflammatory drugs in silicone oil implications for therapeutic efficacy

Retina

Volumn 28, Issue 9, 2008, Pages 1247-1250

  Pastor, Jose Carlos ^a   Del Nozal, Maria Jesus ^b   Zamarron, Ester ^c   Garcia, Maite ^a  

^a UNIVERSITY OF VALLADOLID   (Spain)

^b UNIVERSITY OF VALLADOLID   (Spain)

^c NONE

Author keywords

Dexamethasone; Indomethacin; Nabumetone; Phenylbutazone; Silicone oil; Triamcinolone acetonide

Indexed keywords

CHLOROFORM; D 1881; D 4532; DEXAMETHASONE; ETHER; INDOMETACIN; NABUMETONE; PHENYLBUTAZONE; SILICONE OIL; T 6501; TRIAMCINOLONE ACETONIDE; UNCLASSIFIED DRUG; WATER; ALKANONE; ANTIINFLAMMATORY AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; SOLVENT;

ARTICLE; CONCENTRATION RESPONSE; DISSOLUTION; DRUG DIFFUSION; DRUG EFFICACY; DRUG MIXTURE; DRUG PURIFICATION; DRUG RELEASE; DRUG SOLUBILITY; SOLUBILIZATION; SPECTROPHOTOMETRY; CHEMISTRY; DIFFUSION; DRUG COMBINATION; HUMAN; OSMOLARITY; SOLUBILITY; TIME;

ANTI-INFLAMMATORY AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BUTANONES; CHLOROFORM; DEXAMETHASONE; DIFFUSION; DRUG THERAPY, COMBINATION; ETHER, ETHYL; HUMANS; OSMOLAR CONCENTRATION; PHENYLBUTAZONE; SILICONE OILS; SOLUBILITY; SOLVENTS; SPECTROPHOTOMETRY; TIME FACTORS; TRIAMCINOLONE ACETONIDE; WATER;

EID: 67649205252     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e31817d5bf6     Document Type: Article

References (19)

1. Pastor JC, Zarco JM, Del Nozal MJ, Pampliega A, Marinero P. Clinical consequences of the use of highly purified silicone oil. Comparative study of highly and less purified silicone oil. Eur J Ophthalmol 1998;8:179-183.
2. Pastor JC, del Nozal MJ, Marinero P, Diez O. Colesterol, α-tocopherol, and retinoid concentrations in silicone oil used as a vitreous substitute. Arch Soc Esp Oftalmol 2006;81: 13-19.
3. Pastor JC, de la Rúa RE, Fernandez I, del Nozal Nalda MJ, Jonas JB. Lipophilic substances in intraocular silicone oil. Am J Ophthalmol 2007;143:707-709.
4. Araiz JJ, Refojo MF, Arroyo MH, Leong FL, Albert DM, Tolentino FI. Antiproliferative effect of retinoic acid in intravitreous silicone oil in an animal model of proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 1993;34:522-530.
5. Jonas JB. Concentration of intravitreally injected triamcinolone acetonide in intraocular silicone oil. Br J Ophthalmol 2002;86:1450-1451.
6. Munir WM, Pulido JS, Sharma MC, Buerk BM. Intravitreal triamcinolone for treatment of complicated proliferative vitreoretinopathy and proliferative vitreoretinopathy. Can J Ophthalmol 2005;40:598-604.
7. Moffet AC. Clarke's. Isolation and Identification of Drugs. 2nd ed. London: The Pharmaceutical Press; 1986.
8. Sweetman SC. Martindale. Guía completa de consulta farmacoterapeutica. 2nd ed. Barcelona: Pharma Editores SL; 2006.
9. Heidenkummer HP, Messmer EM, Kampik A. Recurrent vitreoretinal membranes in intravitreal silicone oil tamponade. Morphologic and immunohistochemical studies. Ophthalmologe 1996;93:121-125.
10. Azen SP, Scott IU, Flynn HW Jr, et al. Silicone oil in the repair of complex retinal detachments. A prospective observational multicenter study. Ophthalmology 1998;105:1587-1597.
11. Arroyo MH, Refojo MF, Araiz JJ, Tolentino FI, Cajita VN, Elner VM. Silicone oil as a delivery vehicle for BCNU in rabbit proliferative vitreoretinopathy. Retina 1993;13:245-250.
12. Manzanas L, Marin J, Refojo MF. Retinol in silicone oil for treating proliferative vitreoretinopathy (PVR). Invest Ophthalmol Vis Sci 1990;31:24.
13. Pastor JC. Proliferative vitreoretinopathy: an overview. Surv Ophthalmol 1998;43:3-18.
14. Pastor JC, Rodríguez E, Marcos M, López MI. Combined pharmacologic therapy in a rabbit model of proliferative vitreoretinopathy (PVR). Ophthalmic Res 2000;32:25-29.
15. Pastor JC, de la Rúa RE, Martín F. Proliferative vitreoretinopathy: risk factors and pathobiology. Prog Retin Eye Res 2002;21:127-144.
16. Jonas JB, Schlichtenbrede F. Visual acuity and intraocular pressure after high-dose intravitreal triamcinolone acetonide in selected ocular diseases. Eye 2007; Epub ahead of print.
17. Tong JP, Lam DS, Chan WM, Choy KW, Chan KP, Pang CP. Effects of triamcinolona on the expression of VEGF and PEDF in human retinal pigment epithelial and human umbilical vein endothelial cells. Mol Vis 2006;12:1490-1495.
18. Jonas JB. Intraocular availability of triamcinolone acetonide after intravitreal injection. Am J Ophthalmol 2004;137:560-562.
19. Kosobucki BR, Freeman WR, Cheng L. Photographic estimation of the duration of high dose intravitreal triamcinolone acetonide in the vitrectomised eye. Br J Ophthalmol 2006;90: 705-708.